Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice

Journal of Endocrinology

Volumn 227, Issue 3, 2015, Pages 143-151

  Ben Shmuel, Sarit ^a   Scheinman, Eyal J ^a   Rashed, Rola ^a   Orr, Zila Shen ^a   Gallagher, Emily J ^b   LeRoith, Derek ^a,b   Rostoker, Ran ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Hyperinsulinemia; Insulin resistance; Obesity; Ovariectomy

Indexed keywords

ESTRADIOL; GLUCOSE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; GLUCOSE BLOOD LEVEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BREAST CANCER CELL LINE; BREAST TUMOR; CONTROLLED STUDY; DIABETES MELLITUS; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE DEFICIENCY; HYPERCHOLESTEROLEMIA; MALE; MAMMARY GLAND FAT; METABOLIC DISORDER; METABOLISM; MOUSE; NONHUMAN; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; CANCER TRANSPLANTATION; GENETICS; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAMMARY NEOPLASMS, EXPERIMENTAL; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; FEMALE; INSULIN RESISTANCE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; OVARIECTOMY; PREDIABETIC STATE;

EID: 84949633458     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-15-0310     Document Type: Article

References (55)

1. Alikhani N, Ferguson RD, Novosyadlyy R, Gallagher EJ, Scheinman EJ, Yakar S & LeRoith D 2013 Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. Oncogene 32 961-967. (doi:10.1038/onc.2012.113)
2. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B et al. 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 291 1701-1712. (doi:10.1001/jama.291. 14.1701)
3. Barros RP & Gustafsson JA 2011 Estrogen receptors and the metabolic network. Cell Metabolism 14 289-299. (doi:10.1016/j.cmet. 2011.08.005)
4. Barros RP, Machado UF, Warner M & Gustafsson JA 2006 Muscle GLUT4 regulation by estrogen receptors ERb and ERa. PNAS 103 1605-1608. (doi:10.1073/pnas.0510391103)
5. Bhupathiraju SN & Manson JE 2014 Menopausal hormone therapy and chronic disease risk in the Women's Health Initiative: is timing everything?. Endocrine Practice 20 1201-1213. (doi:10.4158/ EP14205.RA)
6. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman- Wright K, Nilsson S, Gustafsson JA, Efendic S et al. 2006 Evidence that oestrogen receptor-a plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49 588-597. (doi:10.1007/s00125-005-0105-3)
7. Camporez JP, Jornayvaz FR, Lee HY, Kanda S, Guigni BA, Kahn M, Samuel VT, Carvalho CR, Petersen KF, Jurczak MJ et al. 2013 Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. Endocrinology 154 1021-1028. (doi:10.1210/en.2012-1989)
8. Carr MC 2003 The emergence of themetabolic syndrome with menopause. Journal of Clinical Endocrinology and Metabolism 88 2404-2411. (doi:10.1210/jc.2003-030242)
9. Chlebowski RT & Anderson GL 2012 Changing concepts: menopausal hormone therapy and breast cancer. Journal of National Cancer Institute 104 517-527. (doi:10.1093/jnci/djs014)
10. Choi SB, Jang JS & Park S 2005 Estrogen and exercise may enhance b-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats. Endocrinology 146 4786-4794. (doi:10.1210/en.2004-1653)
11. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS & Obin MS 2005 Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research 46 2347-2355. (doi:10.1194/jlr. M500294-JLR200)
12. Clark JB, Palmer CJ & Shaw WN 1983 The diabetic Zucker fatty rat. Proceedings of Society Experimental Biology and Medicine 173 68-75. (doi:10.3181/00379727-173-41611)
13. Coughlin SS, Calle EE, Teras LR, Petrelli J & Thun MJ 2004 Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. American Journal of Epidemiology 159 1160-1167. (doi:10.1093/aje/ kwh161)
14. De Marinis E, Martini C, Trentalance A & Pallottini V 2008 Sex differences in hepatic regulation of cholesterol homeostasis. Journal of Endocrinology 198 635-643. (doi:10.1677/JOE-08-0242)
15. Donahue RP, Bean JA, Donahue RA, Goldberg RB & Prineas RJ 1997 Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study. Diabetes Care 20 1670-1676. (doi:10.2337/diacare.20.11.1670)
16. Espeland MA, Marcovina SM,Miller V, Wood PD, Wasilauskas C, Sherwin R, Schrott H & Bush TL 1998 Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal estrogen/progestin interventions. Circulation 97 979-986. (doi:10.1161/01.CIR.97.10.979)
17. Fernandez AM, Kim JK, Yakar S, Dupont J,Hernandez-Sanchez C, Castle AL, Filmore J, Shulman GI & Le Roith D 2001 Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes and Development 15 1926-1934. (doi:10.1101/gad.908001)
18. Gonzalez C, Alonso A, Alvarez N, Diaz F, Martinez M, Fernandez S & Patterson AM 2000 Role of 17b-estradiol and/or progesterone on insulin sensitivity in the rat: implications during pregnancy. Journal of Endocrinology 166 283-291. (doi:10.1677/joe.0.1660283)
19. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB & Cooke PS 2000 Increased adipose tissue in male and female estrogen receptor-a knockout mice. PNAS 97 12729-12734. (doi:10.1073/pnas.97.23.12729)
20. Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark- Wahnefried W, Kakarala M, Brodie A & Berger NA 2012 Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prevention Research 5 1260-1272. (doi:10.1158/1940-6207. CAPR-12-0140)
21. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S et al. 2000 Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. PNAS 97 12735-12740. (doi:10.1073/pnas.97.23.12735)
22. Kitahara CM, BerringtondeGonzalez A, Freedman ND, Huxley R, Mok Y, Jee SH & Samet JM 2011 Total cholesterol and cancer risk in a large prospective study in Korea. Journal of Clinical Oncology 29 1592-1598. (doi:10.1200/JCO.2010.31.5200)
23. Klebig ML, Wilkinson JE, Geisler JG & Woychik RP 1995 Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. PNAS 92 4728-4732. (doi:10.1073/pnas.92.11. 4728)
24. LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD et al. 2011 Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. Journal of the American Medical Association 305 1305-1314. (doi:10.1001/jama.2011.382)
25. Larsson SC, Mantzoros CS & Wolk A 2007 Diabetes mellitus and risk of breast cancer: a meta-analysis. International Journal of Cancer 121 856-862. (doi:10.1002/ijc.22717)
26. Lemieux C, Phaneuf D, Labrie F, Giguere V, Richard D & Deshaies Y 2005 Estrogen receptor a-mediated adiposity-lowering and hypocholesterolemic actions of the selective estrogen receptor modulator acolbifene. International Journal of Obesity 29 1236-1244. (doi:10.1038/sj.ijo. 0803014)
27. Louet JF, LeMay C & Mauvais-Jarvis F 2004 Antidiabetic actions of estrogen: insight from human and genetic mouse models. Current Atherosclerosis Reports 6 180-185. (doi:10.1007/s11883-004-0030-9)
28. Lovejoy JC, Champagne CM, de Jonge L, Xie H & Smith SR 2008 Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesity 32 949-958. (doi:10.1038/ijo. 2008.25)
29. Makin G & Dive C 2001 Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?. Breast Cancer Research 3 150-153. (doi:10.1186/bcr289)
30. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J & Howard BV 2004 Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47 1175-1187. (doi:10.1007/s00125-004-1448-x)
31. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE & Nurses' Health Study 2003 Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26 1752-1758. (doi:10.2337/diacare.26.6.1752)
32. Morris PG, Hudis CA, Giri D, MorrowM, Falcone DJ, Zhou XK, Du B, Brogi E, Crawford CB, Kopelovich L et al. 2011 Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prevention Research 4 1021-1029. (doi:10.1158/ 1940-6207.CAPR-11-0110)
33. Novosyadlyy R & LeRoith D 2010 Hyperinsulinemia and type 2 diabetes: impact on cancer. Cell Cycle 9 1449-1450. (doi:10.4161/cc.9.8.11512)
34. Novosyadlyy R, Lann DE, Vijayakumar A, Rowzee A, Lazzarino DA, Fierz Y, Carboni JM, Gottardis MM, Pennisi PA, Molinolo AA et al. 2010 Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Research 70 741-751. (doi:10.1158/0008-5472.CAN-09-2141)
35. Nuutila P, Knuuti MJ, Maki M, Laine H, Ruotsalainen U, Teras M, Haaparanta M, Solin O & Yki-Jarvinen H 1995 Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 44 31-36. (doi:10.2337/diab.44.1.31)
36. Paik SG, Michelis MA, Kim YT & Shin S 1982 Induction of insulindependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens. Diabetes 31 724-729. (doi:10.2337/diab.31. 8.724)
37. Paplomata E & O'Regan R 2014 The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers. Therapeutic Advances in Medical Oncology 6 154-166. (doi:10.1177/1758834014530023)
38. Pei XF, Noble MS, Davoli MA, Rosfjord E, Tilli MT, Furth PA, Russell R, Johnson MD & Dickson RB 2004 Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice. In Vitro Cellular & Developmental Biology. Animal 40 14-21. (doi:10.1290/1543- 706X(2004)40!14:ECOPMTO2.0.CO;2)
39. Petrelli JM, Calle EE, Rodriguez C & Thun MJ 2002 Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes & Control 13 325-332. (doi:10. 1023/A:1015288615472)
40. Picard F, Wanatabe M, Schoonjans K, Lydon J, O'Malley BW & Auwerx J 2002 Progesterone receptor knockout mice have an improved glucose homeostasis secondary to b -cell proliferation. PNAS 99 15644-15648. (doi:10.1073/pnas.202612199)
41. Pierobon M & Frankenfeld CL 2013 Obesity as a risk factor for triplenegative breast cancers: a systematic review and meta-analysis. Breast Cancer Research and Treatment 137 307-314. (doi:10.1007/s10549-012- 2339-3)
42. Preston-Martin S, Pike MC, Ross RK, Jones PA & Henderson BE 1990 Increased cell division as a cause of human cancer. Cancer Research 50 7415-7421.
43. Puah JA & Bailey CJ 1985 Insulinotropic effect of ovarian steroid hormones in streptozotocin diabetic female mice. Hormone Metabolic Research 17 216-218. (doi:10.1055/s-2007-1013496)
44. Robinson WR, Tse CK, Olshan AF & Troester MA 2014 Body size across the life course and risk of premenopausal and postmenopausal breast cancer in Black women, the Carolina Breast Cancer Study, 1993-2001. Cancer Causes & Control 25 1101-1117. (doi:10.1007/ s10552-014-0411-5)
45. Rogers NH, Perfield JW II, Strissel KJ, Obin MS & Greenberg AS 2009 Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 150 2161-2168. (doi:10.1210/en.2008-1405)
46. Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J & Russo IH 2006 17-b-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB Journal 20 1622-1634. (doi:10.1096/fj.05-5399com)
47. Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS & Salpeter EE 2006 Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes, Obesity & Metabolism 8 538-554. (doi:10.1111/j.1463-1326. 2005.00545.x)
48. Sciacca L, Vigneri R, Tumminia A, Frasca F, Squatrito S, Frittitta L & Vigneri P 2013 Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients. Nutrition, Metabolism, and Cardiovascular Diseases 23 808-815. (doi:10.1016/j. numecd.2013.05.006)
49. Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, Zhou XK, Blaho VA, Hla T, Yang P et al. 2011 Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prevention Research 4 329-346. (doi:10.1158/ 1940-6207.CAPR-10-0381)
50. Sundaram S, Johnson AR & Makowski L 2013 Obesity, metabolism and the microenvironment: Links to cancer. Journal of Carcinogenesis 12 19. (doi:10.4103/1477-3163.119606)
51. Xu Y, Nedungadi TP, Zhu L, Sobhani N, Irani BG, Davis KE, Zhang X, Zou F, Gent LM, Hahner LD et al. 2011 Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metabolism 14 453-465. (doi:10.1016/j.cmet.2011.08.009)
52. Xu CX, Zhu HH & Zhu YM 2014 Diabetes and cancer: associations, mechanisms, and implications for medical practice. World Journal of Diabetes 5 372-380. (doi:10.4239/wjd.v5.i3.372)
53. Yakar S, Nunez NP, Pennisi P, Brodt P, SunH, Fallavollita L, Zhao H, Scavo L, Novosyadlyy R, Kurshan N et al. 2006 Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology 147 5826-5834. (doi:10.1210/en.2006-0311)
54. Yepuru M, Eswaraka J, Kearbey JD, Barrett CM, Raghow S, Veverka KA, Miller DD, Dalton JT & Narayanan R 2010 Estrogen receptor-{b}- selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. Journal of Biological Chemistry 285 31292-31303. (doi:10.1074/jbc.M110.147850)
55. Yue W, Yager JD, Wang JP, Jupe ER & Santen RJ 2013 Estrogen receptordependent and independent mechanisms of breast cancer carcinogenesis. Steroids 78 161-170. (doi:10.1016/j.steroids.2012.11.001)